SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,710,491 | -13.8% | 47,212 | -15.1% | 0.04% | +17.6% |
| Q4 2022 | $1,983,537 | -2.1% | 55,608 | -7.1% | 0.03% | 0.0% |
| Q3 2022 | $2,026,000 | +248.7% | 59,838 | +232.7% | 0.03% | +209.1% |
| Q1 2022 | $581,000 | +13.7% | 17,986 | +8.4% | 0.01% | +22.2% |
| Q2 2021 | $511,000 | -31.4% | 16,588 | -41.7% | 0.01% | -30.8% |
| Q1 2021 | $745,000 | +127.1% | 28,454 | +118.1% | 0.01% | +116.7% |
| Q4 2020 | $328,000 | -4.7% | 13,045 | -20.9% | 0.01% | -40.0% |
| Q3 2020 | $344,000 | -6.5% | 16,500 | +6.5% | 0.01% | -44.4% |
| Q2 2020 | $368,000 | – | 15,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |